Results 1 to 10 of about 326,995 (379)

Adoptive Immunotherapy beyond CAR T-Cells. [PDF]

open access: yesCancers (Basel), 2021
Adoptive cell immunotherapy (ACT) is a vibrant field of cancer treatment that began progressive development in the 1980s. One of the most prominent and promising examples is chimeric antigen receptor (CAR) T-cell immunotherapy for the treatment of B-cell hematologic malignancies.
Titov A   +9 more
europepmc   +6 more sources

Adoptive T Cell Immunotherapy for Cancer [PDF]

open access: yesRambam Maimonides Medical Journal, 2015
Harnessing the immune system to recognize and destroy tumor cells has been the central goal of anti-cancer immunotherapy. In recent years, there has been an increased interest in optimizing this technology in order to make it a clinically feasible ...
Karlo Perica   +3 more
doaj   +4 more sources

Adoptive Immunotherapy in Chimeras with Donor Lymphocytes [PDF]

open access: yesActa Haematologica, 2003
Allogeneic stem cell transplantation has a well-defined indication in the treatment of hematological malignancies. The beneficial immune effect of allogeneic marrow transplantation has long been known, but only recently have methods been developed to ...
Chen, Xiao   +8 more
core   +6 more sources

Adoptive immunotherapy for cytomegalovirus infection [PDF]

open access: yesJournal of Applied Sciences and Environmental Management, 2005
We reported a case with interstitial pneumonia associated with cytomegalovirus (CMV) infection in whom clinical improvement was observed after the treatment with primary adoptive immunotherapy.
M D Kei Numazaki
doaj   +3 more sources

The Combined Clinical Efficacy and Safety Analysis of Adoptive Immunotherapy with Radiotherapy and Chemotherapy in Non-Small-Cell Lung Cancer: Systematic Review and Meta-Analysis

open access: yesApplied Bionics and Biomechanics, 2022
Objective. To explore the differential efficacy of chemoradiotherapy combined with adoptive immunotherapy and radiochemotherapy alone in patients with non-small-cell lung cancer (NSCLC). Methods.
Zhiming Fan, Honggui He, Liqun Chen
doaj   +2 more sources

ADOPTIVE IMMUNOTHERAPY IN CANINE CHIMERAS1

open access: bronzeTransplantation, 1997
Chimerism and tolerance after bone marrow transplantation provide excellent conditions for adoptive immunotherapy with T cells of the marrow donor. We studied adoptive immunotherapy in dog leukocyte antigen-identical canine littermate chimeras. Mixed chimeras were produced by conditioning treatment with total body irradiation of a dose of 10 Gy, a ...
Hans‐Jochem Kolb   +5 more
openalex   +4 more sources

Adoptive immunotherapy for posttransplantation viral infections [PDF]

open access: hybridBiology of Blood and Marrow Transplantation, 2004
Viral diseases are a major cause of morbidity and mortality after hemopoietic stem cell transplantation. Because viral complications in these patients are clearly associated with the lack of recovery of virus-specific cellular immune responses, reconstitution of the host with in vitro expanded cytotoxic T lymphocytes is a potential approach to prevent ...
Catherine M. Bollard   +4 more
openalex   +4 more sources

Neoantigen‐reactive T cell: An emerging role in adoptive cellular immunotherapy

open access: yesMedComm, 2021
Adoptive cellular immunotherapy harnessing the intrinsic immune system for precise treatment has exhibited preliminary success against malignant tumors.
Yicheng Zhu   +4 more
doaj   +1 more source

Adoptive immunotherapy in postoperative hepatocellular carcinoma: a systemic review. [PDF]

open access: yesPLoS ONE, 2012
PURPOSE: The effectiveness of immunotherapy for postoperative hepatocellular carcinoma patients is still controversial. To address this issue, we did a systemic review of the literatures and analyzed the data with emphasis on the recurrence and survival.
Feng Xie   +8 more
doaj   +1 more source

Anti-Tumor Effects after Adoptive Transfer of IL-12 Transposon-Modified Murine Splenocytes in the OT-I-Melanoma Mouse Model. [PDF]

open access: yesPLoS ONE, 2015
Adoptive transfer of gene modified T cells provides possible immunotherapy for patients with cancers refractory to other treatments. We have previously used the non-viral piggyBac transposon system to gene modify human T cells for potential immunotherapy.
Daniel L Galvan   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy